COBAS E-ELECSYS ANTI-CCP 05031656190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-09-27 for COBAS E-ELECSYS ANTI-CCP 05031656190 manufactured by Roche Diagnostics.

Event Text Entries

[55697750] This event occurred in (b)(6). Unique identifier (udi)#: (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[55697751] The customer received questionable elecsys anti-ccp immunoassay results for one patient when compared to the results from elisa-assay of euroimmun assay and siemens immulite assay. The customer was using cobas e601 analyzer serial number (b)(4). The patient was to take part in a clinical study and was tested for anti-ccp and other study relevant markers. Due to the discrepancy in the anti-ccp results, the patient's participation in the study was in question. The customer wanted confirmation of the results in order to be sure of the "pre-characterization of this patient" for the study. The results from the e601 were 71. 82 u/ml and 71. 76 u/ml (72) (positive) which matched the patient's clinical picture. The result from the siemens assay was 2. 2 u/ml (normal). The result from the elisa assay on 09/03/2016 was 7. 8 u/ml (indeterminate). No adverse event was reported. The medical doctors in charge heavily criticized the elevated result and claimed an assay performance issue. Sample from the patient was submitted for investigation and was tested on a cobas e411 analyzer and an analytical e module analyzer. The results were found comparable to the customer's results and an interfering factor to streptavidin could be excluded. Based on the results, a product problem could not be found.
Patient Sequence No: 1, Text Type: D, B5


[58472045] Additional information was provided that the patient suffers from rheumatoid arthritis and received "methotrexat treatment" during the time the questionable results were generated.
Patient Sequence No: 1, Text Type: N, H10


[58725210] Additional information was received that the results were not used for any diagnostic purpose and were used only for testing of patient for participation in the clinical study. The results were not provided to a person making a treatment decision for the patient. The patient was not adversely affected in any way.
Patient Sequence No: 1, Text Type: N, H10


[61328134] A specific root cause could not be confirmed. From the information provided and the analysis of the sample, a general reagent issue could be excluded.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2016-01467
MDR Report Key5979361
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-09-27
Date of Report2016-12-01
Date of Event2016-09-01
Date Mfgr Received2016-09-05
Date Added to Maude2016-09-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameCOBAS E-ELECSYS ANTI-CCP
Generic NameANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE (CCP)
Product CodeNHX
Date Received2016-09-27
Model NumberNA
Catalog Number05031656190
Lot NumberASKU
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device Availability*
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2016-09-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.